SumDU Repository: Browsing DSpace

Browsing by Keywords tremelimumab

Showing results 1 to 2 of 2

Issue Year	Title	Author(s)	Type	Views	Downloads
2020	Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study	Ferris, R.L.; Haddad, R.; Even, C.; Tahara, M.; Dvorkin, M.; Ciuleanu, T.E.; Clement, P.M.; Mesia, R.; Kutukova, S.; Zholudeva, L.; Daste, A.; Caballero-Daroqui, J.; Keam, B.; Vynnychenko, Ihor Oleksandrovych; Lafond, C.; Shetty, J.; Mann, H.; Fan, J.; Wildsmith, S.; Morsli, N.; Fayette, J.; Licitra, L.	Article	11551137	15050086
2023	Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study	Psyrri, A.; Fayette, J. Vynnychenko; Harrington, K.; Gillison, M.; Ahn, M.-J.; Takahashi, S.; Weiss, J.; Machiels, J.-P.; Baxi, S.; Vasilyev, A.; Karpenko, A.; Dvorkin, M.; Hsieh, C.-Y.; Thungappa, S.C.; Segura, P.P.; Vynnychenko, Ihor Oleksandrovych; Haddad, R.; Kasper, S.; Mauz, P.-S.; Baker, V.; He, P.; Evans, B.; Wildsmith, S.; Olsson, R.F.; Yovine, A.; Kurland, J.F.; Morsli, N.; Seiwert, T.Y.	Article	10	13